Eagle Bay Advisors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-506
| Closed | -$5.99K | – | 775 |
|
2024
Q4 | $5.99K | Hold |
506
| – | – | ﹤0.01% | 668 |
|
2024
Q3 | $5.84K | Hold |
506
| – | – | ﹤0.01% | 947 |
|
2024
Q2 | $5.35K | Hold |
506
| – | – | ﹤0.01% | 686 |
|
2024
Q1 | $5.33K | Hold |
506
| – | – | ﹤0.01% | 708 |
|
2023
Q4 | $5.68K | Hold |
506
| – | – | ﹤0.01% | 615 |
|
2023
Q3 | $5.91K | Hold |
506
| – | – | ﹤0.01% | 658 |
|
2023
Q2 | $5.1K | Hold |
506
| – | – | ﹤0.01% | 664 |
|
2023
Q1 | $3.73K | Hold |
506
| – | – | ﹤0.01% | 698 |
|
2022
Q4 | $4.04K | Hold |
506
| – | – | ﹤0.01% | 683 |
|
2022
Q3 | $2K | Hold |
506
| – | – | ﹤0.01% | 771 |
|
2022
Q2 | $2.06K | Buy |
+506
| New | +$2.06K | ﹤0.01% | 789 |
|
2022
Q1 | – | Sell |
-506
| Closed | -$5K | – | 815 |
|
2021
Q4 | $5K | Buy |
+506
| New | +$5K | ﹤0.01% | 775 |
|